A study investigating the long term (96 weeks) effect of telbivudine in hepatitis B virus-related decompensated and compensated patients
Latest Information Update: 12 Dec 2015
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 12 Dec 2015 New trial record